Contact us

Testimonials
from our strategic partners

“We strongly believe in Ksilink as a key player for effectively bridging the gap between scientific excellence and the pharma industry.”

Jacques Volckmann

Head of R&D, Sanofi, France

“Ksilink’s capacities to apply patient-derived disease models for high-throughput, high-content screening by using AI-driven deep learning computation is outstanding.”

Wolfram Zimmermann

CSO, Myriamed GmbH, Germany

“We see big value in the ability of Ksilink to translate clinical expertise into treatment for diseases with high unmet medical need .”

Andreas Meyer-Lindenberg

Director and CEO, Central Institute of Mental Health, Germany

“We strongly believe in Ksilink’s potential, allowing the generation of valuable first-in-class therapeutic molecules.”

Bert Klebl

Managing Director, Lead Discovery Center, Germany